Mehran RJ, Gil J, Rice DC, Swisher SG , Lee JJ, Lippman SM, Pisters K, Blumenschein G, Hong WK, Tsao A
The publication reported the estimated mean percent change in body weight from baseline to week 68 for each arm, with the combination arm showing a substantially larger estimated reduction than placebo, and the cagrilintide-alone arm showing an intermediate reduction
This approach works well for researchers on established protocols who know their consumption rate and do not want to manage large upfront purchases
GLP-1s May Lead to an Increased Risk of Post-Endoscopy Aspiration Pneumonia by ColoWrap, on May 15, 2024 In a recent large population-based study published in the peer-reviewed Gastroenterology journal, researchers found that glucagon-like peptide-1 receptor agonist (GLP-1RA) medicationssuch as Ozempic and Wegovy that are integrally transforming medications in the management of type 2 diabetes and obesityare associated with a higher risk of post-endoscopy aspiration pneumonia